Literature DB >> 486305

Distribution of misonidazole in human tumours and normal tissues.

D V Ash, M R Smith, R D Bugden.   

Abstract

Levels of misonidazole in human tumours, normal tissues and blood have been measured in patients given a 1g oral dose of drug before surgery or biopsy. The results show that 50--70% of the blood level was found in a wide range of tumours and that similar levels were found in adjacent normal tissues. Good penetration of drug was achieved within tumours, and up to 90--100% of the blood level was found in the necrotic cyst fluid at the centre of some tumours. CSF studies showed free diffusion into the CNS, which was confirmed by finding 50--70% of the blood level within brain tumours. A delay of passage of drugs into the CSF was noted, which was not found for drug diffusion into bile and saliva.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 486305      PMCID: PMC2009904          DOI: 10.1038/bjc.1979.93

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  5 in total

1.  Clinical testing of the radiosensitiser Ro-07-0582. I. Dose tolerance, serum and tumour concentrations.

Authors:  A J Gray; S Dische; G E Adams; I R Flockhart; J L Foster
Journal:  Clin Radiol       Date:  1976-04       Impact factor: 2.350

2.  Radiosensitization by misonidazole (Ro 07-0582). The importance of timing and tumor concentration of sensitizer.

Authors:  N J McNally; J Denekamp; P Sheldon; I R Flockhart; F A Stewart
Journal:  Radiat Res       Date:  1978-03       Impact factor: 2.841

3.  Estimation of the hypoxic cell-sensitiser misonidazole and its O-demethylated metabolite in biological materials by reversed-phase high-performance liquid chromatography.

Authors:  P Workman; C J Little; T R Marten; A D Dale; R J Ruane; I R Flockhart; N M Bleehen
Journal:  J Chromatogr       Date:  1978-05-01

4.  Clinical phase I study of the hypoxic cell radiosensitizer RO-07-0582, a 2-nitroimidazole derivative.

Authors:  R C Urtasun; P Band; J D Chapman; H R Rabin; A F Wilson; C G Fryer
Journal:  Radiology       Date:  1977-03       Impact factor: 11.105

5.  Distribution and tumour cytotoxicity of the radiosensitizer misonidazole (Ro-07-0582) in C57 mice.

Authors:  J E Pedersen; M R Smith; R D Bugden; M J Peckham
Journal:  Br J Cancer       Date:  1979-04       Impact factor: 7.640

  5 in total
  15 in total

1.  Absorption and distribution of vaginally administered misonidazole.

Authors:  D Ash; R Bugden; R Calvert
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

2.  Distribution of nitroimidazoles and L-phenylalanine mustard in mammary adenocarcinoma 16/C tumors.

Authors:  P E Noker; L Simpson-Herren; S D Wagoner
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

3.  Distribution and tumor penetration properties of a radiosensitizer 2-[14C] misonidazole (Ro 07-0582), in mice and rats as studied by whole-body autoradiography.

Authors:  G Akel; P Benard; P Canal; G Soula
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

4.  Growth delay studies in patients with multiple metastases.

Authors:  D V Ash
Journal:  Br J Cancer Suppl       Date:  1980-04

5.  Low concentrations of misonidazole counteract effects of extreme hypoxia on cells in S.

Authors:  E O Pettersen; T Lindmo
Journal:  Br J Cancer       Date:  1981-03       Impact factor: 7.640

6.  Transition from laboratory to clinic in cancer treatment. Abstracts of symposium papers.

Authors: 
Journal:  Br J Cancer       Date:  1981-05       Impact factor: 7.640

7.  Phenytoin shortens the half-life of the hypoxic cell radiosensitizer misonidazole in man: implications for possible reduced toxicity.

Authors:  P Workman; N M Bleehen; C R Wiltshire
Journal:  Br J Cancer       Date:  1980-02       Impact factor: 7.640

8.  Microscopic distribution of misonidazole in mouse tissues.

Authors:  L M Cobb; J Nolan; P O'Neill
Journal:  Br J Cancer       Date:  1989-01       Impact factor: 7.640

9.  The concentration of desmethylmisonidazole in human tumours and in cerebrospinal fluid.

Authors:  S Dische; M I Saunders; P J Riley; J Hauck; M H Bennett; M R Stratford; A I Minchinton
Journal:  Br J Cancer       Date:  1981-03       Impact factor: 7.640

10.  The penetration of misonidazole into a mature structural cartilage.

Authors:  A J Langler; R D Bugden; P Gibson
Journal:  Br J Cancer       Date:  1982-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.